Search Results

integrated into regular clinical practice and run by frontline clinic staff. Screening was linked with follow-up care and services, including psychosocial resources, pain and fatigue clinics, nutrition services, and palliative care, using referral guidelines

confounded by fatigue, depression, anxiety, underlying brain tumors, endocrine dysfunction, nutritional deficiency, alcohol use, and sleep disturbances. 50 Therefore, if dementia is suspected, further evaluation including brain imaging, neuropsychological

unmet needs after treatment. Many patients have also suffered physical side effects and have seen the relationships in their lives undergo dramatic shifts. Patients’ needs often relate to quality of life (fatigue, fear of recurrence) and/or their ability

%, respectively. The most common side effects of nivolumab were fatigue, musculoskeletal pain, decreased appetite, cough, and constipation. Eighty-three patients had tumor samples suitable for PD-L1 expression analysis. Across the prespecified expression levels

men that were evaluated,” explained Dr. Armstrong. Fatigue, fall risk, and hypertension were the most common clinically relevant adverse events associated with enzalutamide treatment. 7 In fact, hypertension occurred 2 to 3 times as often with

SCC. A phase II study was conducted at his center, but was discontinued due to overwhelming fatigue, anorexia, weight loss, and pleural effusion. Other therapies appear to offer more promise in the treatment of cutaneous SCC. Dr. Olencki discussed

therefore initiated therapy with everolimus. After starting everolimus he noted improvement in pain and diarrhea. He had side effects of fatigue, stomatitis, a pustular rash on his fingers and scalp, and mild thrombocytopenia. He had been on everolimus for

hypertension, chronic kidney disease, anemia, and pericardial effusion initially presented with severe fatigue, cognitive impairment, and diffuse bone pain. He also reported muscle pain in his thighs and calves, diminished appetite, and severe lethargy. In a

.4 months. The safety of ibrutinib in MZL is similar to that seen in other diseases. Frequently occurring adverse effects include fatigue, diarrhea, and anemia. Atrial fibrillation should be a reason for concern in patients with cardiac history, said Dr

not so obvious ways,” stated Dr. Melisko. For instance, adverse effects of treatment may include reduced sexual desire, decreased libido, and fatigue. In addition, “Endocrine therapy has a profound impact on both men and women,” she added. Along with